Trabectedin enhances the antitumor effects of IL-12 in triple-negative breast cancer.
Schwarz E, Savardekar H, Zelinskas S, Mouse A, Lapurga G, Lyberger J, Rivaldi A, Ringwalt EM, Miller KE, Yu L, Behbehani GK, Cripe TP, Carson WE.
Schwarz E, et al. Among authors: miller ke.
Cancer Immunol Res. 2025 Jan 7. doi: 10.1158/2326-6066.CIR-24-0775. Online ahead of print.
Cancer Immunol Res. 2025.
PMID: 39777457